Pfizer’s Talzenna Takes On Top Dog Lynparza In Prostate Cancer

Pfizer announced positive topline results from the TALAPRO-2 trial in mCRPC • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D